头孢吡肟对临床常见革兰阴性杆菌的体外抗菌活性研究

夏云; 陈蕾

doi:10.13406/j.cnki.cyxb.2003.02.035

您当前的位置：

首页 >

文章列表页 >

头孢吡肟对临床常见革兰阴性杆菌的体外抗菌活性研究

更新时间：2024-01-17

- 头孢吡肟对临床常见革兰阴性杆菌的体外抗菌活性研究
- The study of in vitro antibacterial activity of cefepime against clinical isolates of Gram negative bacilli strains
- 重庆医科大学学报 2003年第2期页码：228-229
- 作者机构：
  
  1. 重庆医科大学临床学院检验科
  2. 重庆铜梁县人民医院检验科,重庆,400016
  3. ,重庆,402560
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2003.02.035
  中图分类号： R969
- 纸质出版日期：2003，
扫描看全文
[1]夏云,陈蕾.头孢吡肟对临床常见革兰阴性杆菌的体外抗菌活性研究[J].重庆医科大学学报,2003(02):228-229+232.

XIA Yun, et al. The study of in vitro antibacterial activity of cefepime against clinical isolates of Gram negative bacilli strains[J]. Journal of Chongqing Medical University, 2003,(2):228-229.
[1]夏云,陈蕾.头孢吡肟对临床常见革兰阴性杆菌的体外抗菌活性研究[J].重庆医科大学学报,2003(02):228-229+232. DOI： 10.13406/j.cnki.cyxb.2003.02.035.

XIA Yun, et al. The study of in vitro antibacterial activity of cefepime against clinical isolates of Gram negative bacilli strains[J]. Journal of Chongqing Medical University, 2003,(2):228-229. DOI： 10.13406/j.cnki.cyxb.2003.02.035.

摘要

目的 :了解头孢吡肟对革兰阴性杆菌的体外抗菌活性。方法 :利用K -B法测定头孢吡肟对临床分离的常见革兰阴性杆菌的耐药率并与头孢他啶、头孢噻肟和氨曲南的体外药敏实验结果相比较。结果 :共测定 376株细菌对头孢吡肟、氨曲南、头孢他啶、头孢噻肟的耐药率 :大肠埃希菌分别为 5 .8%、10 .1%、 6 .8%、 14 .1%

铜绿假单胞菌分别为 9.7%、 10 .0 %、15 .6 %、37.8% ;阴沟肠杆菌分别为 9.0 %、4 7.3%、4 2 .9%、2 7.2 % ;鲍曼不动杆菌分别为 39.7%、4 2 .6 %、4 4 .1%、5 5 .3% ;肺炎克雷伯菌分别为 7.5 %、16 .7%、12 .8%、16 .7%。结论 :头孢吡肟对革兰阴性杆菌的抗菌活性高于三代头孢菌素和氨曲南

特别是对产AmpC酶的革兰阴性杆菌如阴沟肠杆菌的稳定性佳

具有良好的临床应用价值。

Abstract

Objective: To investigate in vitro antibacterial activity of cefepime against clinical isolates of Gram negative bacilli strains.Methods: The prevalence of cefepime resistance was compared with those of the common third generation cefalosporins such as ceftazidime

cefotaxime and aztreonam. Results: Of the total 376 clinical isolate strains

the resistance for cefepime

aztreonam

ceftazidime

cefotaxime were as follows:Escherichia coli were 5.8%

10.1%

6.8% and 14.1% respectively;Pseudomonas aeruginosa were 9.7%

10.0%

15.6% and 37.8% respectively;Enterobacter cloacae were 9.0%

47.3%

42.9% and 27.2% respectively;Acinetobacter baumannii were 39.7%

42.6%

44.1% and 55.3% respectively;Klebsiella pneumoniae were 7.5%

16.7%

12.8% and 16.7% respectively.Conclusion: In vitro antibacterial activity of cefepime against Gram negative bacilli strains was significantly higher than the common third generation of cefalosporins and aztreonam especially for AmpC productive strains such as Enterobacter cloacae

cefepime

has good stability and is suitable for clinical empirical therapy.

关键词

头孢吡肟体外抗菌活性AmpC酶

Keywords

CefepimeIn virto antibacterial activityAmpC

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

国产头孢吡肟治疗下呼吸道细菌感染疗效及安全性评价